August 2, 2012 — Using a microneedle to inject drugs into the suprachoroidal space may provide a method for drug delivery to the posterior segment of the eye that is less invasive and more targeted ...
Please provide your email address to receive an email when new articles are posted on . The phase 1/2 PRISM trial evaluated the safety, efficacy and durability of 4D-150. Participants experienced ...
Please provide your email address to receive an email when new articles are posted on . This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; ...
An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results